- Report
- December 2021
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- August 2023
Japan, United States, ... Japan, United States, Europe
From €1450EUR$1,500USD£1,246GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2659EUR$2,750USD£2,284GBP
- Report
- February 2020
- 198 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4351EUR$4,500USD£3,737GBP
From €532EUR$550USD£457GBP
The Pseudomonas Test market is a segment of the Infectious Disease Testing industry that focuses on the detection of Pseudomonas bacteria. This bacteria is a common cause of infection in humans, and can cause a range of illnesses, from mild to severe. Tests for Pseudomonas are used to diagnose and monitor the progression of the infection, as well as to determine the best course of treatment. Tests are available in a variety of formats, including culture, PCR, and antigen detection.
The Pseudomonas Test market is highly competitive, with a number of companies offering products and services. These include Abbott, Becton Dickinson, Bio-Rad, Cepheid, DiaSorin, Hologic, Luminex, Quidel, Roche, and Thermo Fisher Scientific. Show Less Read more